Genome Valley Pharma Parks And Incubators Private Limited - Company Profile

It is a infrastructure and utilities private limited company based in Thane, Maharashtra, India, established in 2021.
2021 Thane, Maharashtra, India Active
Last Updated:
Access Report
About Genome Valley Pharma Parks And Incubators Private Limited

Genome Valley Pharma Parks And Incubators Private Limited, a active private limited company, was established on 10 June 2021 in Thane, Maharashtra, India. Engaging in general infrastructure services within the real estate sector, it holds CIN: U24290MH2021PTC459547. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹30.10 Cr and a paid-up capital of ₹30.00 Cr.

It upholds a compliant status. Its leadership includes Praveen Kumar Poonamallee Sridharan (Director), Raghvendra Chandak (Director), Ashish Balram Singh (Additional Director). Past directors included Pooja Baheti, Pachipala Dora Swamy, Ashish Balram Singh. It holds ₹285.00 Cr open charges and no settled loans. Its latest AGM occurred on 01 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot Number Gen-2/1/C/Part A, Block D, Trans Thane Creek Industrial Area, Bonsari Village,, Kukshet, Shiravane, Taluka Thane, Registration District, Sub-District Thane, Juinagar, Nerul,, Thane, Maharashtra, 400705.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290MH2021PTC459547

  • Registration Number

    459547

  • Incorporation Date

    10 June 2021

  • Authorized Capital

    ₹30.10 Cr

  • Paid-Up Capital

    ₹30.00 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 30.10 Cr
  • Paid Up Capital ₹ 30.00 Cr
  • Company Age 4 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 285.00 Cr
Company report

Genome Valley Pharma Parks And Incubators Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Genome Valley Pharma Parks And Incubators Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Genome Valley Pharma Parks And Incubators Private Limited?
Current Directors
Name Designation Appointment Date Status
Praveen Kumar Poonamallee Sridharan Director 09 Dec 2022 Current
Raghvendra Chandak Director 09 Dec 2022 Current
Ashish Balram Singh Additional Director 24 Oct 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 09 Dec 2022 Past
Pramod Abcsdd Director 30 Dec 2021 Past
Pramod Abcsdd Director 15 Oct 2025 Past
Pramod Abcsdd Director 02 May 2025 Past
Pramod Abcsdd Director 01 Jan 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Genome Valley Pharma Parks And Incubators.
Genome Valley Pharma Parks And Incubators revenue growth over time
Genome Valley Pharma Parks And Incubators profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Genome Valley Pharma Parks And Incubators?

Unlock access to Genome Valley Pharma Parks And Incubators's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,850,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 285.00 Cr
Latest Charge Details
Date Lender Amount Status
29 Nov 2023 Axis Bank Limited ₹285.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Genome Valley Pharma Parks And Incubators?

Unlock and access historical data on people associated with Genome Valley Pharma Parks And Incubators, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Genome Valley Pharma Parks And Incubators, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genome Valley Pharma Parks And Incubators's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Genome Valley Pharma Parks And Incubators
Recent Activity within the Organization
  • Director Appointment

    Ashish Balram Singh was appointed as a Additional Director was appointed as a Additional Director on 24 Oct 2025 & has been associated with this company since 4 months 4 days . was recorded as a recent event.

  • Annual General Meeting

    The activity Genome Valley Pharma Parks And Incubators Private Limited last Annual general meeting of members was held on 01 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Genome Valley Pharma Parks And Incubators Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Charges

    The activity A charge with Axis Bank Limited of Rs. 285.00 Cr registered on 29 Nov 2023 with Charge ID 100837689 was modified on 12 Mar 2024. was completed.

  • Charges

    Progress on A charge with Axis Bank Limited amounted to Rs. 285.00 Cr with Charge ID 100837689 was registered on 29 Nov 2023. was documented.

  • Director Appointment

    The activity Yashi Tiwari was appointed as a Company Secretary was appointed as a Company Secretary on 23 Oct 2023 & has been associated with this company since 2 years 4 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Genome Valley Pharma Parks And Incubators Private Limited?

The CIN of Genome Valley Pharma Parks And Incubators Private Limited is U24290MH2021PTC459547.

Where is Genome Valley Pharma Parks And Incubators Private Limited headquartered?

Genome Valley Pharma Parks And Incubators Private Limited is headquartered at Plot Number Gen-2/1/C/Part A, Block D, Trans Thane Creek Industrial Area, Bonsari Village,, Kukshet, Shiravane, Taluka Thane, Registration District, Sub-District Thane, Juinagar, Nerul,, Thane, Maharashtra, 400705.

When was Genome Valley Pharma Parks And Incubators Private Limited incorporated?

Genome Valley Pharma Parks And Incubators Private Limited was incorporated on 10 June 2021.

Who are the current directors of Genome Valley Pharma Parks And Incubators Private Limited?

The current directors of Genome Valley Pharma Parks And Incubators Private Limited are

What is the primary industry of Genome Valley Pharma Parks And Incubators Private Limited?

The primary industry of Genome Valley Pharma Parks And Incubators Private Limited is Real Estate.

Is Genome Valley Pharma Parks And Incubators Private Limited a listed company?

Genome Valley Pharma Parks And Incubators Private Limited is unlisted.

What is the capital structure of Genome Valley Pharma Parks And Incubators Private Limited?

The authorized capital of Genome Valley Pharma Parks And Incubators Private Limited is ₹30.10 Cr, and the paid-up capital is ₹30.00 Cr.

What is the compliance status of Genome Valley Pharma Parks And Incubators Private Limited?

The compliance status of Genome Valley Pharma Parks And Incubators Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available